Nature Nanotechnology, ISSN 1748-3387, 11/2013, Volume 8, Issue 11, pp. 859 - 864
Signatures of Majorana fermions have recently been reported from measurements on hybrid superconductor-semiconductor nanowire devices. Majorana fermions are...
CONDUCTANCE | NANOWIRE JUNCTIONS | TOPOLOGICAL QUANTUM COMPUTATION | CRYSTAL-GROWTH | SUPERCONDUCTOR | ANYONS | SUPERCURRENT | MAJORANA FERMIONS | JOSEPHSON-JUNCTIONS | Devices | Nanocomposites | Fermions | Indium antimonides | Intermetallics | Nanomaterials | Nanostructure | Electric wire
CONDUCTANCE | NANOWIRE JUNCTIONS | TOPOLOGICAL QUANTUM COMPUTATION | CRYSTAL-GROWTH | SUPERCONDUCTOR | ANYONS | SUPERCURRENT | MAJORANA FERMIONS | JOSEPHSON-JUNCTIONS | Devices | Nanocomposites | Fermions | Indium antimonides | Intermetallics | Nanomaterials | Nanostructure | Electric wire
Journal Article
NATURE NANOTECHNOLOGY, ISSN 1748-3387, 11/2013, Volume 8, Issue 11, pp. 859 - 864
Signatures of Majorana fermions have recently been reported from measurements on hybrid superconductor-semiconductor nanowire devices. Majorana fermions are...
CONDUCTANCE | NANOWIRE JUNCTIONS | TOPOLOGICAL QUANTUM COMPUTATION | CRYSTAL-GROWTH | SUPERCONDUCTOR | MATERIALS SCIENCE, MULTIDISCIPLINARY | ANYONS | NANOSCIENCE & NANOTECHNOLOGY | SUPERCURRENT | MAJORANA FERMIONS | JOSEPHSON-JUNCTIONS
CONDUCTANCE | NANOWIRE JUNCTIONS | TOPOLOGICAL QUANTUM COMPUTATION | CRYSTAL-GROWTH | SUPERCONDUCTOR | MATERIALS SCIENCE, MULTIDISCIPLINARY | ANYONS | NANOSCIENCE & NANOTECHNOLOGY | SUPERCURRENT | MAJORANA FERMIONS | JOSEPHSON-JUNCTIONS
Journal Article
Physical Review Letters, ISSN 0031-9007, 11/2017, Volume 119, Issue 18, p. 187704
Junctions created by coupling two superconductors via a semiconductor nanowire in the presence of high magnetic fields are the basis for the potential...
CONDUCTANCE | SYSTEM | DEVICE | INSB NANOWIRE | STATE | PHYSICS, MULTIDISCIPLINARY | Physics - Mesoscale and Nanoscale Physics | Materials Science | Condensed Matter | Quantum Physics | Cristallography | Material chemistry | Physics | Chemical Sciences
CONDUCTANCE | SYSTEM | DEVICE | INSB NANOWIRE | STATE | PHYSICS, MULTIDISCIPLINARY | Physics - Mesoscale and Nanoscale Physics | Materials Science | Condensed Matter | Quantum Physics | Cristallography | Material chemistry | Physics | Chemical Sciences
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 02/2017, Volume 69, Issue 2, pp. 362 - 375
Objective Epratuzumab, a monoclonal antibody that targets CD22, modulates B cell signaling without substantial reductions in the number of B cells. The aim of...
RHEUMATOID-ARTHRITIS | ALLEVIATE | CORTICOSTEROID USE | RITUXIMAB | BILAG-2004 INDEX | VALIDATION | RHEUMATOLOGY | DISEASE-ACTIVITY | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Male | Treatment Outcome | Lupus | Response rates | Corticoids | Drugs | Therapy | Statistical analysis | Corticosteroids | Central nervous system | Medical services | Clinical trials | Patients | Two phase | Domains | CD22 antigen | Chronic conditions | Randomization | Systemic lupus erythematosus | Lymphocytes B | Quality | Monoclonal antibodies | Safety | Autoimmune diseases | Antinuclear antibodies | Deoxyribonucleic acid--DNA | Systemic Lupus Erythematosus
RHEUMATOID-ARTHRITIS | ALLEVIATE | CORTICOSTEROID USE | RITUXIMAB | BILAG-2004 INDEX | VALIDATION | RHEUMATOLOGY | DISEASE-ACTIVITY | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Humans | Lupus Erythematosus, Systemic - drug therapy | Adult | Female | Male | Treatment Outcome | Lupus | Response rates | Corticoids | Drugs | Therapy | Statistical analysis | Corticosteroids | Central nervous system | Medical services | Clinical trials | Patients | Two phase | Domains | CD22 antigen | Chronic conditions | Randomization | Systemic lupus erythematosus | Lymphocytes B | Quality | Monoclonal antibodies | Safety | Autoimmune diseases | Antinuclear antibodies | Deoxyribonucleic acid--DNA | Systemic Lupus Erythematosus
Journal Article
Arthritis & Rheumatism, ISSN 0004-3591, 02/2010, Volume 62, Issue 2, pp. 351 - 358
Objective Multiple lines of evidence suggest that sex hormones may play a role in the pathogenesis or clinical expression of rheumatoid arthritis (RA). Studies...
Steroids - administration & dosage | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Steroids - pharmacokinetics | Sulfasalazine - administration & dosage | Medication Adherence | Estrogen Receptor alpha - agonists | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Antirheumatic Agents - adverse effects | Placebos | Postmenopause | Antirheumatic Agents - pharmacokinetics | Female | Methotrexate - administration & dosage | Drug Therapy, Combination | Steroids - adverse effects
Steroids - administration & dosage | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Steroids - pharmacokinetics | Sulfasalazine - administration & dosage | Medication Adherence | Estrogen Receptor alpha - agonists | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Antirheumatic Agents - adverse effects | Placebos | Postmenopause | Antirheumatic Agents - pharmacokinetics | Female | Methotrexate - administration & dosage | Drug Therapy, Combination | Steroids - adverse effects
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.